0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Blood Product - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-1089
Home | Market Reports | Health| Nursing
Global Blood Product Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Blood Product - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-1089
Report
March 2024
Pages:156
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blood Product - Market Size

The global market for Blood Product was estimated to be worth US$ 28320 million in 2023 and is forecast to a readjusted size of US$ 47570 million by 2030 with a CAGR of 7.6% during the forecast period 2024-2030

Blood Product - Market

Blood Product - Market

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
The major players in global blood product market include Takeda, CSL, etc. The top 3 players occupy about 60% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood Product, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Blood Product by region & country, by Type, and by Application.
The Blood Product market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Product.
Market Segmentation

Scope of Blood Product - Market Report

Report Metric Details
Report Name Blood Product - Market
Forecasted market size in 2030 US$ 47570 million
CAGR 7.6%
Forecasted years 2024 - 2030
Segment by Type:
  • Albumin
  • Immunoglobulin
  • Clotting Factor
  • Others
Segment by Application
  • Bleeding Wound
  • Immunodeficiency
  • HBV
  • Tetanus
  • Rabies
  • Hemophilia
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, Shanghai RAAS, China Biologic Products, Hualan Biological Engineering Inc., Beijing Tiantan Biological Products Corp, Pacific Shuanglin, Boya Bio-Pharmaceutical, Paisi Feike Biology Pharmacy Co., Ltd., Xinjiang Deyuan Bioengineering, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Shenzhen Weiguang, Shanxi Kangbao, Nanyue Biopharming Corporation Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Blood Product manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Blood Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Blood Product in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Blood Product - Market size in 2030?

Ans: The Blood Product - Market size in 2030 will be US$ 47570 million.

What is the market share of major companies in Blood Product - Market?

Ans: The top 3 players occupy about 60% shares of the global market.

Who are the main players in the Blood Product - Market report?

Ans: The main players in the Blood Product - Market are Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL, Shanghai RAAS, China Biologic Products, Hualan Biological Engineering Inc., Beijing Tiantan Biological Products Corp, Pacific Shuanglin, Boya Bio-Pharmaceutical, Paisi Feike Biology Pharmacy Co., Ltd., Xinjiang Deyuan Bioengineering, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Shenzhen Weiguang, Shanxi Kangbao, Nanyue Biopharming Corporation Ltd

What are the Application segmentation covered in the Blood Product - Market report?

Ans: The Applications covered in the Blood Product - Market report are Bleeding Wound, Immunodeficiency, HBV, Tetanus, Rabies, Hemophilia, Others

What are the Type segmentation covered in the Blood Product - Market report?

Ans: The Types covered in the Blood Product - Market report are Albumin, Immunoglobulin, Clotting Factor, Others

1 Market Overview
1.1 Blood Product Product Introduction
1.2 Global Blood Product Market Size Forecast
1.3 Blood Product Market Trends & Drivers
1.3.1 Blood Product Industry Trends
1.3.2 Blood Product Market Drivers & Opportunity
1.3.3 Blood Product Market Challenges
1.3.4 Blood Product Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Blood Product Players Revenue Ranking (2023)
2.2 Global Blood Product Revenue by Company (2019-2024)
2.3 Key Companies Blood Product Manufacturing Base Distribution and Headquarters
2.4 Key Companies Blood Product Product Offered
2.5 Key Companies Time to Begin Mass Production of Blood Product
2.6 Blood Product Market Competitive Analysis
2.6.1 Blood Product Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Blood Product Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Albumin
3.1.2 Immunoglobulin
3.1.3 Clotting Factor
3.1.4 Others
3.2 Global Blood Product Sales Value by Type
3.2.1 Global Blood Product Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Blood Product Sales Value, by Type (2019-2030)
3.2.3 Global Blood Product Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Bleeding Wound
4.1.2 Immunodeficiency
4.1.3 HBV
4.1.4 Tetanus
4.1.5 Rabies
4.1.6 Hemophilia
4.1.7 Others
4.2 Global Blood Product Sales Value by Application
4.2.1 Global Blood Product Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Blood Product Sales Value, by Application (2019-2030)
4.2.3 Global Blood Product Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Blood Product Sales Value by Region
5.1.1 Global Blood Product Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Blood Product Sales Value by Region (2019-2024)
5.1.3 Global Blood Product Sales Value by Region (2025-2030)
5.1.4 Global Blood Product Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Blood Product Sales Value, 2019-2030
5.2.2 North America Blood Product Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Blood Product Sales Value, 2019-2030
5.3.2 Europe Blood Product Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Blood Product Sales Value, 2019-2030
5.4.2 Asia Pacific Blood Product Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Blood Product Sales Value, 2019-2030
5.5.2 South America Blood Product Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Blood Product Sales Value, 2019-2030
5.6.2 Middle East & Africa Blood Product Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Blood Product Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Blood Product Sales Value
6.3 United States
6.3.1 United States Blood Product Sales Value, 2019-2030
6.3.2 United States Blood Product Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Blood Product Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Blood Product Sales Value, 2019-2030
6.4.2 Europe Blood Product Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Blood Product Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Blood Product Sales Value, 2019-2030
6.5.2 China Blood Product Sales Value by Type (%), 2023 VS 2030
6.5.3 China Blood Product Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Blood Product Sales Value, 2019-2030
6.6.2 Japan Blood Product Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Blood Product Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Blood Product Sales Value, 2019-2030
6.7.2 South Korea Blood Product Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Blood Product Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Blood Product Sales Value, 2019-2030
6.8.2 Southeast Asia Blood Product Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Blood Product Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Blood Product Sales Value, 2019-2030
6.9.2 India Blood Product Sales Value by Type (%), 2023 VS 2030
6.9.3 India Blood Product Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Profile
7.1.2 Takeda Main Business
7.1.3 Takeda Blood Product Products, Services and Solutions
7.1.4 Takeda Blood Product Revenue (US$ Million) & (2019-2024)
7.1.5 Takeda Recent Developments
7.2 CSL
7.2.1 CSL Profile
7.2.2 CSL Main Business
7.2.3 CSL Blood Product Products, Services and Solutions
7.2.4 CSL Blood Product Revenue (US$ Million) & (2019-2024)
7.2.5 CSL Recent Developments
7.3 Grifols
7.3.1 Grifols Profile
7.3.2 Grifols Main Business
7.3.3 Grifols Blood Product Products, Services and Solutions
7.3.4 Grifols Blood Product Revenue (US$ Million) & (2019-2024)
7.3.5 Octapharma Recent Developments
7.4 Octapharma
7.4.1 Octapharma Profile
7.4.2 Octapharma Main Business
7.4.3 Octapharma Blood Product Products, Services and Solutions
7.4.4 Octapharma Blood Product Revenue (US$ Million) & (2019-2024)
7.4.5 Octapharma Recent Developments
7.5 Kedrion
7.5.1 Kedrion Profile
7.5.2 Kedrion Main Business
7.5.3 Kedrion Blood Product Products, Services and Solutions
7.5.4 Kedrion Blood Product Revenue (US$ Million) & (2019-2024)
7.5.5 Kedrion Recent Developments
7.6 LFB Group
7.6.1 LFB Group Profile
7.6.2 LFB Group Main Business
7.6.3 LFB Group Blood Product Products, Services and Solutions
7.6.4 LFB Group Blood Product Revenue (US$ Million) & (2019-2024)
7.6.5 LFB Group Recent Developments
7.7 Biotest
7.7.1 Biotest Profile
7.7.2 Biotest Main Business
7.7.3 Biotest Blood Product Products, Services and Solutions
7.7.4 Biotest Blood Product Revenue (US$ Million) & (2019-2024)
7.7.5 Biotest Recent Developments
7.8 BPL
7.8.1 BPL Profile
7.8.2 BPL Main Business
7.8.3 BPL Blood Product Products, Services and Solutions
7.8.4 BPL Blood Product Revenue (US$ Million) & (2019-2024)
7.8.5 BPL Recent Developments
7.9 Shanghai RAAS
7.9.1 Shanghai RAAS Profile
7.9.2 Shanghai RAAS Main Business
7.9.3 Shanghai RAAS Blood Product Products, Services and Solutions
7.9.4 Shanghai RAAS Blood Product Revenue (US$ Million) & (2019-2024)
7.9.5 Shanghai RAAS Recent Developments
7.10 China Biologic Products
7.10.1 China Biologic Products Profile
7.10.2 China Biologic Products Main Business
7.10.3 China Biologic Products Blood Product Products, Services and Solutions
7.10.4 China Biologic Products Blood Product Revenue (US$ Million) & (2019-2024)
7.10.5 China Biologic Products Recent Developments
7.11 Hualan Biological Engineering Inc.
7.11.1 Hualan Biological Engineering Inc. Profile
7.11.2 Hualan Biological Engineering Inc. Main Business
7.11.3 Hualan Biological Engineering Inc. Blood Product Products, Services and Solutions
7.11.4 Hualan Biological Engineering Inc. Blood Product Revenue (US$ Million) & (2019-2024)
7.11.5 Hualan Biological Engineering Inc. Recent Developments
7.12 Beijing Tiantan Biological Products Corp
7.12.1 Beijing Tiantan Biological Products Corp Profile
7.12.2 Beijing Tiantan Biological Products Corp Main Business
7.12.3 Beijing Tiantan Biological Products Corp Blood Product Products, Services and Solutions
7.12.4 Beijing Tiantan Biological Products Corp Blood Product Revenue (US$ Million) & (2019-2024)
7.12.5 Beijing Tiantan Biological Products Corp Recent Developments
7.13 Pacific Shuanglin
7.13.1 Pacific Shuanglin Profile
7.13.2 Pacific Shuanglin Main Business
7.13.3 Pacific Shuanglin Blood Product Products, Services and Solutions
7.13.4 Pacific Shuanglin Blood Product Revenue (US$ Million) & (2019-2024)
7.13.5 Pacific Shuanglin Recent Developments
7.14 Boya Bio-Pharmaceutical
7.14.1 Boya Bio-Pharmaceutical Profile
7.14.2 Boya Bio-Pharmaceutical Main Business
7.14.3 Boya Bio-Pharmaceutical Blood Product Products, Services and Solutions
7.14.4 Boya Bio-Pharmaceutical Blood Product Revenue (US$ Million) & (2019-2024)
7.14.5 Boya Bio-Pharmaceutical Recent Developments
7.15 Paisi Feike Biology Pharmacy Co., Ltd.
7.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Profile
7.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Main Business
7.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Products, Services and Solutions
7.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Revenue (US$ Million) & (2019-2024)
7.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
7.16 Xinjiang Deyuan Bioengineering
7.16.1 Xinjiang Deyuan Bioengineering Profile
7.16.2 Xinjiang Deyuan Bioengineering Main Business
7.16.3 Xinjiang Deyuan Bioengineering Blood Product Products, Services and Solutions
7.16.4 Xinjiang Deyuan Bioengineering Blood Product Revenue (US$ Million) & (2019-2024)
7.16.5 Xinjiang Deyuan Bioengineering Recent Developments
7.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
7.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Profile
7.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Main Business
7.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Products, Services and Solutions
7.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Revenue (US$ Million) & (2019-2024)
7.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
7.18 Shenzhen Weiguang
7.18.1 Shenzhen Weiguang Profile
7.18.2 Shenzhen Weiguang Main Business
7.18.3 Shenzhen Weiguang Blood Product Products, Services and Solutions
7.18.4 Shenzhen Weiguang Blood Product Revenue (US$ Million) & (2019-2024)
7.18.5 Shenzhen Weiguang Recent Developments
7.19 Shanxi Kangbao
7.19.1 Shanxi Kangbao Profile
7.19.2 Shanxi Kangbao Main Business
7.19.3 Shanxi Kangbao Blood Product Products, Services and Solutions
7.19.4 Shanxi Kangbao Blood Product Revenue (US$ Million) & (2019-2024)
7.19.5 Shanxi Kangbao Recent Developments
7.20 Nanyue Biopharming Corporation Ltd
7.20.1 Nanyue Biopharming Corporation Ltd Profile
7.20.2 Nanyue Biopharming Corporation Ltd Main Business
7.20.3 Nanyue Biopharming Corporation Ltd Blood Product Products, Services and Solutions
7.20.4 Nanyue Biopharming Corporation Ltd Blood Product Revenue (US$ Million) & (2019-2024)
7.20.5 Nanyue Biopharming Corporation Ltd Recent Developments
8 Industry Chain Analysis
8.1 Blood Product Industrial Chain
8.2 Blood Product Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Blood Product Sales Model
8.5.2 Sales Channel
8.5.3 Blood Product Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Blood Product Market Trends
    Table 2. Blood Product Market Drivers & Opportunity
    Table 3. Blood Product Market Challenges
    Table 4. Blood Product Market Restraints
    Table 5. Global Blood Product Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Blood Product Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Blood Product Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Blood Product Product Type
    Table 9. Key Companies Time to Begin Mass Production of Blood Product
    Table 10. Global Blood Product Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Product as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Blood Product Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Blood Product Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Blood Product Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Blood Product Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Blood Product Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Blood Product Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Blood Product Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Blood Product Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Blood Product Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Blood Product Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Blood Product Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Blood Product Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Blood Product Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Blood Product Sales Value by Region (2019-2024) & (%)
    Table 27. Global Blood Product Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Blood Product Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Blood Product Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Blood Product Sales Value, (2025-2030) & (US$ Million)
    Table 31. Takeda Basic Information List
    Table 32. Takeda Description and Business Overview
    Table 33. Takeda Blood Product Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Blood Product Business of Takeda (2019-2024)
    Table 35. Takeda Recent Developments
    Table 36. CSL Basic Information List
    Table 37. CSL Description and Business Overview
    Table 38. CSL Blood Product Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Blood Product Business of CSL (2019-2024)
    Table 40. CSL Recent Developments
    Table 41. Grifols Basic Information List
    Table 42. Grifols Description and Business Overview
    Table 43. Grifols Blood Product Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Blood Product Business of Grifols (2019-2024)
    Table 45. Grifols Recent Developments
    Table 46. Octapharma Basic Information List
    Table 47. Octapharma Description and Business Overview
    Table 48. Octapharma Blood Product Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Blood Product Business of Octapharma (2019-2024)
    Table 50. Octapharma Recent Developments
    Table 51. Kedrion Basic Information List
    Table 52. Kedrion Description and Business Overview
    Table 53. Kedrion Blood Product Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Blood Product Business of Kedrion (2019-2024)
    Table 55. Kedrion Recent Developments
    Table 56. LFB Group Basic Information List
    Table 57. LFB Group Description and Business Overview
    Table 58. LFB Group Blood Product Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Blood Product Business of LFB Group (2019-2024)
    Table 60. LFB Group Recent Developments
    Table 61. Biotest Basic Information List
    Table 62. Biotest Description and Business Overview
    Table 63. Biotest Blood Product Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Blood Product Business of Biotest (2019-2024)
    Table 65. Biotest Recent Developments
    Table 66. BPL Basic Information List
    Table 67. BPL Description and Business Overview
    Table 68. BPL Blood Product Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Blood Product Business of BPL (2019-2024)
    Table 70. BPL Recent Developments
    Table 71. Shanghai RAAS Basic Information List
    Table 72. Shanghai RAAS Description and Business Overview
    Table 73. Shanghai RAAS Blood Product Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Blood Product Business of Shanghai RAAS (2019-2024)
    Table 75. Shanghai RAAS Recent Developments
    Table 76. China Biologic Products Basic Information List
    Table 77. China Biologic Products Description and Business Overview
    Table 78. China Biologic Products Blood Product Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Blood Product Business of China Biologic Products (2019-2024)
    Table 80. China Biologic Products Recent Developments
    Table 81. Hualan Biological Engineering Inc. Basic Information List
    Table 82. Hualan Biological Engineering Inc. Description and Business Overview
    Table 83. Hualan Biological Engineering Inc. Blood Product Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Blood Product Business of Hualan Biological Engineering Inc. (2019-2024)
    Table 85. Hualan Biological Engineering Inc. Recent Developments
    Table 86. Beijing Tiantan Biological Products Corp Basic Information List
    Table 87. Beijing Tiantan Biological Products Corp Description and Business Overview
    Table 88. Beijing Tiantan Biological Products Corp Blood Product Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Blood Product Business of Beijing Tiantan Biological Products Corp (2019-2024)
    Table 90. Beijing Tiantan Biological Products Corp Recent Developments
    Table 91. Pacific Shuanglin Basic Information List
    Table 92. Pacific Shuanglin Description and Business Overview
    Table 93. Pacific Shuanglin Blood Product Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Blood Product Business of Pacific Shuanglin (2019-2024)
    Table 95. Pacific Shuanglin Recent Developments
    Table 96. Boya Bio-Pharmaceutical Basic Information List
    Table 97. Boya Bio-Pharmaceutical Description and Business Overview
    Table 98. Boya Bio-Pharmaceutical Blood Product Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Blood Product Business of Boya Bio-Pharmaceutical (2019-2024)
    Table 100. Boya Bio-Pharmaceutical Recent Developments
    Table 101. Paisi Feike Biology Pharmacy Co., Ltd. Basic Information List
    Table 102. Paisi Feike Biology Pharmacy Co., Ltd. Description and Business Overview
    Table 103. Paisi Feike Biology Pharmacy Co., Ltd. Blood Product Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Blood Product Business of Paisi Feike Biology Pharmacy Co., Ltd. (2019-2024)
    Table 105. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments
    Table 106. Xinjiang Deyuan Bioengineering Basic Information List
    Table 107. Xinjiang Deyuan Bioengineering Description and Business Overview
    Table 108. Xinjiang Deyuan Bioengineering Blood Product Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Blood Product Business of Xinjiang Deyuan Bioengineering (2019-2024)
    Table 110. Xinjiang Deyuan Bioengineering Recent Developments
    Table 111. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Basic Information List
    Table 112. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Description and Business Overview
    Table 113. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Blood Product Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Blood Product Business of Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (2019-2024)
    Table 115. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments
    Table 116. Shenzhen Weiguang Basic Information List
    Table 117. Shenzhen Weiguang Description and Business Overview
    Table 118. Shenzhen Weiguang Blood Product Products, Services and Solutions
    Table 119. Revenue (US$ Million) in Blood Product Business of Shenzhen Weiguang (2019-2024)
    Table 120. Shenzhen Weiguang Recent Developments
    Table 121. Shanxi Kangbao Basic Information List
    Table 122. Shanxi Kangbao Description and Business Overview
    Table 123. Shanxi Kangbao Blood Product Products, Services and Solutions
    Table 124. Revenue (US$ Million) in Blood Product Business of Shanxi Kangbao (2019-2024)
    Table 125. Shanxi Kangbao Recent Developments
    Table 126. Nanyue Biopharming Corporation Ltd Basic Information List
    Table 127. Nanyue Biopharming Corporation Ltd Description and Business Overview
    Table 128. Nanyue Biopharming Corporation Ltd Blood Product Products, Services and Solutions
    Table 129. Revenue (US$ Million) in Blood Product Business of Nanyue Biopharming Corporation Ltd (2019-2024)
    Table 130. Nanyue Biopharming Corporation Ltd Recent Developments
    Table 131. Key Raw Materials Lists
    Table 132. Raw Materials Key Suppliers Lists
    Table 133. Blood Product Downstream Customers
    Table 134. Blood Product Distributors List
    Table 135. Research Programs/Design for This Report
    Table 136. Key Data Information from Secondary Sources
    Table 137. Key Data Information from Primary Sources
    Table 138. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Blood Product Product Picture
    Figure 2. Global Blood Product Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Blood Product Sales Value (2019-2030) & (US$ Million)
    Figure 4. Blood Product Report Years Considered
    Figure 5. Global Blood Product Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Blood Product Revenue in 2023
    Figure 7. Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Albumin Picture
    Figure 9. Immunoglobulin Picture
    Figure 10. Clotting Factor Picture
    Figure 11. Others Picture
    Figure 12. Global Blood Product Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Blood Product Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of Bleeding Wound
    Figure 15. Product Picture of Immunodeficiency
    Figure 16. Product Picture of HBV
    Figure 17. Product Picture of Tetanus
    Figure 18. Product Picture of Rabies
    Figure 19. Product Picture of Hemophilia
    Figure 20. Product Picture of Others
    Figure 21. Global Blood Product Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Blood Product Sales Value Market Share by Application, 2023 & 2030
    Figure 23. North America Blood Product Sales Value (2019-2030) & (US$ Million)
    Figure 24. North America Blood Product Sales Value by Country (%), 2023 VS 2030
    Figure 25. Europe Blood Product Sales Value (2019-2030) & (US$ Million)
    Figure 26. Europe Blood Product Sales Value by Country (%), 2023 VS 2030
    Figure 27. Asia Pacific Blood Product Sales Value (2019-2030) & (US$ Million)
    Figure 28. Asia Pacific Blood Product Sales Value by Country (%), 2023 VS 2030
    Figure 29. South America Blood Product Sales Value (2019-2030) & (US$ Million)
    Figure 30. South America Blood Product Sales Value by Country (%), 2023 VS 2030
    Figure 31. Middle East & Africa Blood Product Sales Value (2019-2030) & (US$ Million)
    Figure 32. Middle East & Africa Blood Product Sales Value by Country (%), 2023 VS 2030
    Figure 33. Key Countries/Regions Blood Product Sales Value (%), (2019-2030)
    Figure 34. United States Blood Product Sales Value, (2019-2030) & (US$ Million)
    Figure 35. United States Blood Product Sales Value by Type (%), 2023 VS 2030
    Figure 36. United States Blood Product Sales Value by Application (%), 2023 VS 2030
    Figure 37. Europe Blood Product Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Europe Blood Product Sales Value by Type (%), 2023 VS 2030
    Figure 39. Europe Blood Product Sales Value by Application (%), 2023 VS 2030
    Figure 40. China Blood Product Sales Value, (2019-2030) & (US$ Million)
    Figure 41. China Blood Product Sales Value by Type (%), 2023 VS 2030
    Figure 42. China Blood Product Sales Value by Application (%), 2023 VS 2030
    Figure 43. Japan Blood Product Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Japan Blood Product Sales Value by Type (%), 2023 VS 2030
    Figure 45. Japan Blood Product Sales Value by Application (%), 2023 VS 2030
    Figure 46. South Korea Blood Product Sales Value, (2019-2030) & (US$ Million)
    Figure 47. South Korea Blood Product Sales Value by Type (%), 2023 VS 2030
    Figure 48. South Korea Blood Product Sales Value by Application (%), 2023 VS 2030
    Figure 49. Southeast Asia Blood Product Sales Value, (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia Blood Product Sales Value by Type (%), 2023 VS 2030
    Figure 51. Southeast Asia Blood Product Sales Value by Application (%), 2023 VS 2030
    Figure 52. India Blood Product Sales Value, (2019-2030) & (US$ Million)
    Figure 53. India Blood Product Sales Value by Type (%), 2023 VS 2030
    Figure 54. India Blood Product Sales Value by Application (%), 2023 VS 2030
    Figure 55. Blood Product Industrial Chain
    Figure 56. Blood Product Manufacturing Cost Structure
    Figure 57. Channels of Distribution (Direct Sales, and Distribution)
    Figure 58. Bottom-up and Top-down Approaches for This Report
    Figure 59. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Addison's Disease Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-15W2944
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Cryochambers Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37W6047
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Drug Repurposing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23J5563
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Consumer mHealth Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11I6310
Mon Apr 15 00:00:00 UTC 2024

Add to Cart